Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07042217 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation for Depression
A NA study of Unipolar Depression, sponsored by Soterix Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT07042217 is a NA study of Unipolar Depression that is actively recruiting participants, run by Soterix Medical. The registered enrollment target is 25 participants, below the 82-participant average among 8 other Unipolar Depression trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07042217, a NA study of Unipolar Depression, is actively recruiting participants, sponsored by Soterix Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol in 25 adults with unipolar depression.
Conditions Studied
Interventions
- DEVICE transcranial direct current stimulation (tDCS) and mindfulness instruction
- DEVICE Sham tDCS and Mindfulness
Study Locations (1)
New Jersey
- Soterix Medical, Inc. - Woodbridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07042217
The ClinicalTrials.gov registry entry for NCT07042217 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 82-participant average among 8 other Unipolar Depression trials with a reported enrollment target (70% lower). The listed sponsor is Soterix Medical, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Unipolar Depression appearing as the primary indexed condition, and to 2 interventions - of which transcranial direct current stimulation (tDCS) and mindfulness instruction is the first listed.
NCT07042217 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07042217 about?
NCT07042217 is a clinical study titled "Transcranial Direct Current Stimulation for Depression". This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol in 25 adults with unipolar depression.
What is the current status of trial NCT07042217?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-07-01. Estimated completion is 2026-09-01.
What conditions does trial NCT07042217 study?
This clinical trial studies the following conditions: Unipolar Depression.
What interventions are being tested in trial NCT07042217?
The interventions under investigation include: transcranial direct current stimulation (tDCS) and mindfulness instruction (DEVICE), Sham tDCS and Mindfulness (DEVICE).
Who is sponsoring clinical trial NCT07042217?
This trial is sponsored by Soterix Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07042217 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unipolar Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Tao Calligraphy Meditation and Energized Water on Depression
RECRUITING · NA
-
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
RECRUITING · Phase 4
-
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
RECRUITING · Phase 2
-
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
COMPLETED · Phase 3
-
Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
COMPLETED · Phase 3
-
Home-administered tDCS for Treatment of Depression
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.